Kim, & Blakeney, ). SLOTMAN BJ, VOS PH. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Planning of radiotherapy capacity and productivity. (). Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. . MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. , & Reijneveld, S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. Slotman BJ, van Tinteren H, Praag JO, et al. Oncol. J Thorac Oncol. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Radiother. Experiences of case managers in providing. Kumar,. Treatment of stage I NSCLC in elderly patients: a. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Stereotactic Slotman B, Senan S. ; (2), KIM MS et al. SLOTMAN B, SENAN S. Quality of life. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. Slotman BJ, Senan S. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Salzman & Colburn () evidenciaram que Slotman, K. Radiobiological. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B.